Want to join the conversation?
During 4Q15, $VAR's Oncology Systems gross orders were $919MM, equal to the year-ago quarter and up 5% in constant currency. Orders for the fiscal year totaled $2.7Bil, equal with the prior year, but up 6% in constant currency in line with long-term mid-single digit growth expectations for this business.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th